Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21672053 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy
Conditions: Rhinoconjunctivitis;   Allergies
Interventions: Drug: CYT003-QbG10;   Drug: Placebo

Indicates status has not been verified in more than two years